Best Healthcare Market Research Companies in Chile (2026 Guide)
An independent guide to the leading healthcare market research companies operating in Chile for 2026. This guide profiles 5 firms across pharmaceutical research, ISP/ANAMED regulatory intelligence, FONASA/ISAPRE system analysis, HEOR, and competitive intelligence — comparing capabilities and Chile-specific expertise to help you select the right healthcare research partner in South America's most stable and high-income pharmaceutical market.
Published 2026-06-11 · By BioNixus Research Team
5
Firms Profiled
$4B+
Pharma Market
ISP/ANAMED
Regulatory
8
FAQs Answered
Best Healthcare Market Research Companies in Chile (2026)
The following healthcare market research companies have demonstrated operations or project delivery in Chile as of 2026, covering pharmaceutical, regulatory, FONASA/ISAPRE reimbursement, and health economics research:
- 1BioNixus — Best for: Chile and South America healthcare research execution, ISP/ANAMED regulatory awareness, FONASA/ISAPRE system intelligence, and Spanish-English bilingual delivery
- 2IQVIA Chile — Best for: IMS pharma data, real-world evidence, sales force effectiveness, pharmaceutical market measurement
- 3Ipsos Healthcare Chile — Best for: quantitative and qualitative pharmaceutical research, physician and patient surveys, brand tracking
- 4Kantar Health (LATAM) — Best for: consumer health tracking, patient research, health and wellness insights across LATAM
- 5Euromonitor International — Best for: syndicated market sizing, Chile country reports, consumer health category intelligence, five-year forecasts
Chile Healthcare Market Research Landscape 2026
Chile is South America's most stable pharmaceutical market and ranks among the region's highest in per-capita healthcare spending. Valued at over $4 billion USD, the Chilean pharma market benefits from a strong institutional framework, a well-educated patient population, and a dual healthcare system that divides coverage between FONASA (Fondo Nacional de Salud) — the public insurer covering approximately 80% of the population — and ISAPRE (Instituciones de Salud Previsional), the private health insurance system serving higher-income segments.
ISP (Instituto de Salud Pública) is Chile's primary pharmaceutical regulator, with ANAMED (Agencia Nacional de Medicamentos) operating as its dedicated medicines regulatory division. ANAMED oversees drug registration, bioequivalence requirements, and clinical trial authorisation. MINSAL (Ministerio de Salud) sets national health policy and manages FONASA. Health technology assessment is conducted through ETESA (Evaluación de Tecnologías Sanitarias), which informs reimbursement and formulary decisions under the AUGE/GES guaranteed health conditions framework.
Santiago is Chile's dominant pharmaceutical hub, housing multinational affiliates, private hospital groups, and leading research universities. The Chilean market is characterised by high patient compliance, a growing chronic disease burden (cardiovascular, diabetes, oncology), and strong demand for innovative therapies. The right healthcare market research partner in Chile must combine ISP/ANAMED regulatory knowledge, FONASA/ISAPRE system fluency, bilingual Spanish-English research capability, and access to physician panels across Santiago and Chile's key regional cities.
5 Healthcare Market Research Companies in Chile (2026)
Firms are assessed by use case and market positioning — select based on your research type, sector, and in-country requirements.
BioNixus
Best for: Chile and South America healthcare research execution, ISP/ANAMED regulatory awareness, FONASA/ISAPRE system intelligence, and Spanish-English bilingual delivery
BioNixus is a global healthcare and market research firm headquartered in the USA with offices in the UK and the Middle East, delivering comprehensive pharmaceutical and healthcare market research across Chile and South America. With 15+ years of experience serving 48+ global clients across 17+ countries, BioNixus brings pharmaceutical usage and attitude studies, KOL identification and mapping, physician panel surveys, ISP/ANAMED regulatory awareness, FONASA/ISAPRE reimbursement intelligence, HEOR, ETESA-aligned health technology assessment support, and competitive intelligence to the Chile market. BioNixus executes fully bilingual Spanish-English research with knowledge of Chile's dual public-private healthcare architecture and AUGE/GES guaranteed health conditions framework. As a global firm comparable in scope to IQVIA and Ipsos Healthcare, BioNixus offers multinational pharma companies rigorous, decision-ready research quality across all therapeutic areas relevant to the Chilean market.
Key strengths
- Full-service pharmaceutical U&A, KOL mapping, and physician surveys for Chile
- ISP/ANAMED regulatory awareness and FONASA/ISAPRE market access intelligence
- ETESA-aligned HEOR and health technology assessment support
- Spanish-English bilingual field execution in Santiago and Chilean regions
- AUGE/GES guaranteed health conditions framework research
- South America competitive intelligence and regional benchmarking
IQVIA Chile
Best for: IMS pharma data, real-world evidence, sales force effectiveness, pharmaceutical market measurement
IQVIA serves Chile through its regional LATAM network with IMS prescription and sales data, real-world evidence programmes, and pharmaceutical market analytics. IQVIA's market measurement databases provide granular tracking of pharmaceutical sales across FONASA, ISAPRE, and private pharmacy channels in Chile. Their commercial and consulting capabilities support market access, pricing strategy, and sales force optimisation for multinational pharmaceutical clients operating in the Chilean market.
Key strengths
- IMS pharma sales data and market measurement for Chile
- Real-world evidence and outcomes research programmes
- Sales force effectiveness and commercial analytics
- LATAM multi-market benchmarking and competitive intelligence
Ipsos Healthcare Chile
Best for: quantitative and qualitative pharmaceutical research, physician and patient surveys, brand tracking
Ipsos Healthcare operates in Chile through its Santiago office, delivering quantitative surveys, qualitative studies, and digital research across pharmaceutical and consumer health categories. Ipsos Chile supports multinational pharma clients with brand health tracking, physician perception studies, patient journey mapping, and treatment decision research. Their fieldwork capabilities cover Santiago and Chile's major regional centres, with rigorous sampling standards appropriate for Chile's relatively small but sophisticated patient population.
Key strengths
- Quantitative and qualitative pharmaceutical surveys for Chile
- Physician and patient research with validated methodologies
- Brand tracking and treatment decision-making studies
- Chile and South Cone regional research capability
Kantar Health (LATAM)
Best for: consumer health tracking, patient research, health and wellness insights across LATAM
Kantar Health covers Chile and the broader Latin America region through its LATAM research network, leveraging global panel infrastructure for consumer health, patient behaviour, and wellness tracking studies. Kantar's Chile engagements support pharmaceutical and consumer health clients with patient adherence research, health behaviour segmentation, and consumer wellness tracking. Their LATAM positioning allows for direct Chile-to-region benchmarking across key therapeutic and consumer health categories.
Key strengths
- Consumer health and patient behaviour tracking
- Health and wellness consumer segmentation
- Patient adherence and behaviour research
- LATAM regional benchmarking and multi-country studies
Euromonitor International
Best for: syndicated market sizing, Chile country reports, consumer health category intelligence, five-year forecasts
Euromonitor International provides syndicated market intelligence for Chile across healthcare, consumer health, and consumer goods categories. Their Passport database delivers market sizing, competitive landscape analysis, and five-year forecasts for OTC healthcare, personal care, and FMCG categories in Chile. Euromonitor does not conduct custom primary research — their value lies in standardised market data for market entry assessment, category benchmarking, and competitive intelligence across Chile and the wider South America region.
Key strengths
- Syndicated Chile market data and country intelligence reports
- Consumer health and OTC category market sizing
- Five-year market forecasts and competitive landscape analysis
- South America multi-country comparative intelligence
Chile Healthcare Market Research Capabilities Comparison
| Capability | BioNixus | IQVIA Chile | Ipsos Healthcare | Kantar Health | Euromonitor |
|---|---|---|---|---|---|
| Custom primary research (qual + quant) | Full-service | Selective / analytics-led | Full-service | Full-service | None (syndicated only) |
| ISP/ANAMED regulatory awareness | Yes | Yes | Partial | Limited | No |
| Physician & KOL recruitment | Yes | Yes | Yes | Limited | No |
| FONASA/ISAPRE reimbursement research | Yes | Yes | Partial | Limited | No |
| Spanish-English bilingual delivery | Standard | Standard | Standard | Standard | Reports only |
| Syndicated pharma market data | Via custom research | IMS/MIDAS full portfolio | Limited | Consumer health panels | Full portfolio |
Key Considerations for Healthcare Market Research in Chile
ISP/ANAMED Regulatory Environment
ISP (Instituto de Salud Pública) and its ANAMED division regulate pharmaceutical registration, bioequivalence, and clinical trials in Chile. Chile has one of the more rigorous and stable pharmaceutical regulatory frameworks in Latin America, with well-defined requirements for product registration and post-market surveillance. Research supporting ANAMED submissions or ETESA health technology evaluations must meet high evidence standards. ETESA's role in informing AUGE/GES coverage decisions makes HEOR capability particularly important for innovative therapy market access.
FONASA/ISAPRE Dual Insurance System
Chile's dual healthcare system creates distinct market access pathways. FONASA (the public insurer) covers approximately 80% of the population with tiered benefit levels (Grupos A-D), while ISAPREs serve higher-income segments with more comprehensive private coverage. Research must distinguish between public formulary pathways (FONASA reimbursement, AUGE/GES guarantees) and private channel dynamics (ISAPRE and out-of-pocket). The significant income stratification between FONASA and ISAPRE populations also creates distinct patient behaviour and treatment preference profiles.
High Per-Capita Spending and Innovation Uptake
Chile has the highest per-capita healthcare expenditure in South America and a patient population with relatively high health literacy and adherence rates. This creates favourable conditions for innovative therapy uptake, brand differentiation research, and premium consumer health studies. Chile is also frequently used as a proof-of-concept market for broader South America launches, making high-quality Chile-specific evidence highly leverageable for regional market entry decisions.
Frequently Asked Questions
What are the best healthcare market research companies in Chile?
Leading healthcare market research companies in Chile include BioNixus, IQVIA Chile, Ipsos Healthcare Chile, Kantar Health, and Euromonitor International. BioNixus is a global healthcare market research firm with Chile and South America execution capability covering pharmaceutical U&A, ISP/ANAMED regulatory awareness, FONASA/ISAPRE market access intelligence, physician surveys, KOL mapping, and HEOR.
How much does healthcare market research cost in Chile?
Custom healthcare market research in Chile typically ranges from $15,000 to $55,000 per project depending on methodology, therapeutic area, and scope. Given Chile's smaller population relative to Brazil or Mexico, physician recruitment panels may be more limited, which can affect project timelines and costs. HEOR and ETESA-aligned health technology assessment studies typically range from $25,000 to $75,000+.
What is ANAMED and why does it matter for pharmaceutical research in Chile?
ANAMED (Agencia Nacional de Medicamentos) is the medicines regulatory division of Chile's ISP, responsible for pharmaceutical registration, bioequivalence requirements, and clinical trial authorisation. For pharmaceutical market research, ANAMED's regulatory framework shapes the evidence requirements for product approval and formulary inclusion. Chile's bioequivalence programme is among the most rigorous in South America, making regulatory-aware research partners essential for market access strategy.
What is the FONASA/ISAPRE system and how does it affect market access?
Chile's healthcare system is split between FONASA (public insurer covering ~80% of the population) and ISAPREs (private health insurers). Market access for pharmaceuticals must address both the FONASA public formulary — including AUGE/GES guaranteed health conditions coverage — and the private ISAPRE channel. The income stratification between FONASA and ISAPRE populations creates distinct demand profiles and pricing dynamics that require separate research approaches.
What is ETESA and how does it affect HEOR research in Chile?
ETESA (Evaluación de Tecnologías Sanitarias) is Chile's health technology assessment unit within MINSAL, which evaluates the clinical effectiveness, cost-effectiveness, and budget impact of health technologies for inclusion in FONASA reimbursement and AUGE/GES coverage decisions. Research supporting ETESA evaluations requires rigorous HEOR methodology including systematic reviews, economic modelling, and budget impact analysis — making HTA-capable research partners particularly valuable in Chile.
How do I recruit physicians for market research in Chile?
Physician recruitment in Chile is concentrated in Santiago, which houses Chile's major teaching hospitals (Hospital del Salvador, Hospital Clínico UC, Clínica Las Condes) and specialist medical centres. BioNixus maintains LATAM professional networks for physician surveys and KOL mapping that include Chile-based specialists across key therapeutic areas. Given the smaller total physician population compared to Brazil or Mexico, early panel planning is recommended for specialist studies.
What is the size of the pharmaceutical market in Chile?
The Chile pharmaceutical market is valued at over $4 billion USD, with per-capita pharmaceutical spending among the highest in Latin America. The market is growing at approximately 5-7% annually, driven by chronic disease expansion, increased oncology and specialty therapy uptake, and FONASA/ISAPRE reimbursement expansions. The private pharmacy channel is highly developed, with large retail pharmacy chains (Farmacias Ahumada, Cruz Verde, Salcobrand) playing a significant role in OTC and branded generics distribution.
Does BioNixus conduct healthcare research in Chile?
Yes. BioNixus is a global healthcare and market research firm with Chile and South America execution capability, serving pharmaceutical and biotech clients with pharmaceutical U&A, KOL mapping, physician surveys, ISP/ANAMED regulatory intelligence, FONASA/ISAPRE market access research, HEOR, and competitive intelligence. Contact us to discuss your Chile healthcare research requirements.
Plan Healthcare Market Research in Chile
BioNixus delivers custom healthcare and pharmaceutical market research across Chile and South America — physician surveys, KOL mapping, ISP/ANAMED regulatory intelligence, FONASA/ISAPRE market access research, HEOR, and competitive intelligence with bilingual Spanish-English delivery.
Request a Proposal